Study Watch vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Verily
VS
by RhythmScience

AI Verdict

Study Watch is a prescription-only wearable device designed for continuous physiological monitoring and data collection primarily in clinical research settings. In contrast, Rhythm360 is an AI-powered platform that unifies and analyzes cardiac monitoring data from various third-party devices to provide actionable insights for clinical management. While both leverage AI in cardiology and remote monitoring, Study Watch focuses on generating its own data for research, whereas Rhythm360 optimizes the management and interpretation of data from existing devices for clinical practice.

Choose Study Watch if…

Choose Verily Study Watch if your primary objective is to conduct rigorous clinical research that demands continuous, multi-modal physiological data directly from a dedicated wearable device. This tool is ideal for studies focused on developing new algorithms, understanding complex physiological patterns, or investigating novel biomarkers with high-fidelity sensor data.

View Study Watch →

Choose Rhythm360 if…

Choose Rhythm360 if your cardiology clinic needs to streamline the management of cardiac patients by unifying data from a diverse array of existing monitoring devices. This platform excels at reducing alert fatigue through AI-driven triage, integrating seamlessly with EHRs, and automating billing processes, thereby optimizing clinical workflows and improving patient care efficiency.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Study Watch Rhythm360
Pricing Unknown Flexible pricing model that scales with clinic size and platform usage.
Deployment The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 offers a more direct and comprehensive usability experience for clinicians by integrating disparate data, providing a mobile application, and streamlining workflows through AI-driven alert triage and EHR integration. Study Watch's usability is primarily for patients wearing the device and researchers accessing data, rather than direct clinical workflow enhancement.

Clinical Value

Rhythm360

Rhythm360 provides immediate and actionable clinical insights for managing specific cardiac conditions, directly impacting patient care and clinician efficiency by reducing alert fatigue and optimizing treatment. While Study Watch offers valuable data for research, its direct clinical application for day-to-day patient management is less explicit than Rhythm360's targeted solutions.

Pricing & Value

Rhythm360

Rhythm360 offers a transparent, scalable SaaS pricing model, allowing potential customers to understand the cost structure, even if it's considered premium. Study Watch's pricing is not publicly available, making it impossible to assess its value proposition.

Enterprise Readiness

Rhythm360

Rhythm360 demonstrates superior enterprise readiness through its extensive bi-directional EHR integrations with major systems and automated CPT code documentation and billing, which are crucial for seamless adoption and operational efficiency in healthcare organizations. While Study Watch has FDA clearance and strong compliance, Rhythm360's practical integration features make it more immediately deployable within existing enterprise workflows.

Innovation

Rhythm360

Rhythm360's innovation lies in its sophisticated AI-driven approach to aggregating, normalizing, and interpreting disparate cardiac data from various vendors, significantly streamlining complex clinical workflows and reducing alert fatigue. Study Watch is innovative in its advanced multi-sensor data collection, but Rhythm360's application of AI to solve a critical, widespread operational and clinical problem in cardiology stands out.

Support & Docs

Rhythm360

Rhythm360 explicitly offers an optional 24/7/365 oversight service by certified cardiac technicians, indicating a robust and comprehensive support structure. Study Watch provides no information regarding its support or documentation, making it impossible to evaluate.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Study Watch Rhythm360
Product Name Study Watch Rhythm360
Primary Function/Description Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Company Verily Life Sciences RhythmScience
Target Specialties Cardiology, Neurology, Sleep Medicine Cardiology
Key Differentiating Features Continuous physiological monitoring, multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), long battery life (up to one week), on-demand single-channel ECG, irregular pulse monitor. Vendor-neutral data aggregation (all major OEMs), AI-driven alert triage, bi-directional EHR integration (Epic, Cerner, Athenahealth, etc.), automated CPT code documentation and billing, optional 24/7/365 oversight by certified cardiac technicians (CCTs).

Videos

Demos, reviews, and walkthroughs featuring Study Watch and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Verily Study Watch is a prescription-only wearable device designed for non-invasive, continuous physiological monitoring in clinical research. Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data from various devices to provide actionable insights for managing hypertension, heart failure, and rhythm in clinical practice.
The Verily Study Watch is a proprietary wearable device that collects its own physiological data, including ECG, heart rate, and movement. In contrast, Rhythm360 is a vendor-neutral platform that aggregates cardiac monitoring data from various major OEM devices, such as Medtronic, Boston Scientific, Abbott, and Biotronik.
Rhythm360 offers bi-directional integration with major EHR systems like Epic, Cerner, Athenahealth, and others, and includes automated CPT code documentation and billing for remote monitoring services. The Verily Study Watch uploads data to Verily's cloud platform for analysis, but its description does not detail specific EHR integration or automated billing features.
The Verily Study Watch utilizes algorithms and machine learning for cloud-based data processing of continuous physiological monitoring data. Rhythm360 employs AI for alert triage to reduce fatigue and speed response times, AI data normalization, and predictive algorithms for heart failure management.
The Verily Study Watch is designed to support Cardiology, Neurology, and Sleep Medicine through its continuous physiological monitoring capabilities. Rhythm360 is specifically focused on Cardiology, offering comprehensive features for hypertension, heart failure, and rhythm management.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.